Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.
NCT05291039
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Inflammatory Bowel Diseases
Interventions
DRUG:
Infliximab
DRUG:
Adalimumab
Sponsor
Rehab Werida